Search

On July 1, Partners launched a new, mobile-based system to track attendance and CME credit for Ophthalmology Grand Rounds and the Retina Service Conference. Here’s how it works: Log in to Your Account Visit the Partners Office of Continuing Professional Development If you are a Partners employee...

The Tej Kohli Foundation has pledged $2 million over five years to establish the Tej Kohli Cornea Program at Mass. Eye and Ear, which will accelerate innovative and collaborative research to achieve unprecedented breakthroughs in corneal disease. “We are really excited to embark on this partnership...

Ye Sun, MD, PhD (Boston Children's Hospital)National Eye Institute: $2,210,000 over five yearsPhotoreceptor determination of retinal blood vessel growth in retinopathy Joseph Ciolino, MD (Mass. Eye and Ear)US Army Medical Research Acquisition Activity: $2,098,767 over three yearsSteroid-eluting...

OCU400, a novel gene therapy platform developed by Neena Haider, PhD, Harvard Medical School Associate Professor of Ophthalmology and Associate Scientist at the Schepens Eye Research Institute of Mass. Eye and Ear, and licensed to biopharmaceutical company Ocugen, Inc., has been granted orphan drug...